M/18/070 Cooperatief H2/Primacy Healthcare 21 (Aquilant) [2018] IECompA m18070 (26 September 2018)

M/18/070 Cooperatief H2/Primacy Healthcare 21 (Aquilant) [2018] IECompA m18070 (26 September 2018)

The Commission determined that the proposed acquisition would not substantially lessen competition in any market for goods or services in Ireland.

Parties
Acquirer: Cooperatief H2 Equity Partners Fund V U. A; Acquirer: Primacy Healthcare 21 Holding Company Unlimited Company; Target: Primacy Healthcare 21 Limited; Target: Healthcare Acquisition Limited
Jurisdiction
Ireland
Judgment Date
26 September 2018
Procedural Posture
Merger Control / Phase 1 Clearance
Outcome
cleared
Legal Topics
Merger Control, Joint Control Acquisition, Sole Control Acquisition

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2
Sign in to unlock

Parties

Cooperatief H2 Equity Partners Fund V U. A

Acquirer

Primacy Healthcare 21 Holding Company Unlimited Company

Acquirer

Primacy Healthcare 21 Limited

Target

Healthcare Acquisition Limited

Target

Procedural Posture

Merger Control / Phase 1 Clearance

  1. 1 Whether the proposed acquisition would substantially lessen competition in the healthcare sector

Ratio Decidendi

The Commission determined that the proposed acquisition would not substantially lessen competition in any market for goods or services in Ireland.

Court Disposition

cleared

Orders

  • Acquisition by Cooperatief H2 Equity Partners Fund V U. A and Primacy Healthcare 21 Holding Company Unlimited Company of joint control of Primacy Healthcare 21 Limited is cleared.
  • Acquisition of sole control of Healthcare Acquisition Limited by Primacy Healthcare 21 Limited is cleared.